Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
15.73B | 13.60B | 12.59B | 12.08B | 11.38B | 12.23B | Gross Profit |
2.43B | 1.87B | 1.72B | 1.66B | 1.53B | 1.75B | EBIT |
802.51M | 253.65M | 207.31M | 181.43M | 160.42M | 202.25M | EBITDA |
1.12B | 555.36M | 469.71M | 456.51M | 465.07M | 493.71M | Net Income Common Stockholders |
648.62M | 251.95M | 167.08M | 143.43M | 124.09M | 149.12M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
899.00M | 954.88M | 1.13B | 921.91M | 850.90M | 937.97M | Total Assets |
22.26B | 16.80B | 15.03B | 16.41B | 14.36B | 14.40B | Total Debt |
10.62B | 6.26B | 4.09B | 4.97B | 6.31B | 6.37B | Net Debt |
9.72B | 5.31B | 2.97B | 4.05B | 5.46B | 5.43B | Total Liabilities |
16.81B | 11.90B | 10.67B | 12.24B | 10.50B | 10.81B | Stockholders Equity |
5.45B | 4.90B | 4.37B | 4.16B | 3.85B | 3.59B |
Cash Flow | Free Cash Flow | ||||
0.00 | -2.27B | 1.08B | 1.45B | -32.85M | -2.31B | Operating Cash Flow |
0.00 | -1.90B | 1.29B | 1.89B | 198.15M | -2.21B | Investing Cash Flow |
0.00 | -370.50M | -158.97M | -440.26M | -182.32M | 292.88M | Financing Cash Flow |
0.00 | 2.09B | -920.58M | -1.38B | -102.89M | 2.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥9.29B | 9.92 | 3.71% | 9.95% | -17.59% | ||
72 Outperform | ¥9.19B | 9.33 | 3.78% | 0.75% | 12.11% | ||
71 Outperform | ¥9.03B | 21.35 | 0.71% | 19.16% | 67.89% | ||
69 Neutral | ¥9.36B | 10.64 | 0.56% | 9.79% | -25.96% | ||
67 Neutral | ¥8.93B | 7.58 | 3.11% | 10.57% | 4.16% | ||
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% | |
62 Neutral | ¥10.04B | 18.71 | 2.26% | 15.54% | -47.78% |